Dear business partners,
We have thoroughly assessed the situation arising from the requirements set out in the legislation for continuing to place so-called legacy IVDDs (i.e., products that meet the requirements of Article 110 of the IVDR) on the market and have made the following decisions:
Unfortunately, we will no longer supply selected IVD products from our portfolio that are legacy IVDD devices and classified in group C according to IVDR criteria (listed below).
Please note that most of these products are currently in stock. These batches have already been manufactured and placed on the market; therefore, in accordance with the provision of the art. 110 par. 4, may continue to be supplied (to be made available on the market or put into service) with the CE-IVD status until their expiry date. Any newly manufactured batches will be supplied as RUO products only. Information on the availability of IVD batches is reflected in the CE-IVD/RUO indication displayed for each item on this websites.
| ES3049A | eSens N.gonorrhoeae/M.genitalium QL PCR kit | IVD batch in stock |
| ES3083A | eSens HPV HR 14 genotype QT PCR kit, variant 4C | IVD batch in stock |
| ES3200A | eSens HSV QL PCR kit | IVD batch in stock |
| ES4100B | eSens F2/F5 SNP PCR kit | Not in stock |
| ES4200B | eSens BRCA1 SNP PCR kit | IVD batch in stock |
| ES4201B | eSens BCR-ABL QT PCR kit | IVD batch in stock |
| ES3310B | eSens NA RespiViral Multiplex | Not in stock |
| ES3311A | eSens NA SARS-CoV-2/Influenza A/B Multiplex | IVD batch in stock |
With regard to the other legacy IVDDs in our portfolio, namely those that will fall under Class B and the remaining 60 eSens kits that will fall under Class C according to the IVDR criteria, we have decided to take the necessary steps to meet the applicable requirements for their continued marketing within the maximum time limits allowed by the IVDR.
Thank you for your understanding. Should you have any questions feel free to contact us.
Your Ecoli Dx team
Stay connected with Ecoli Dx for the latest news, updates, and insights in PCR diagnostics. Follow us on LinkedIn and subscribe to our newsletter to stay informed about new product launches, upcoming events, and trends.